Runtian Wang
-
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 4
- Oncology top 10%
- Cancer Cells and Metastasis 7
-
- Immune cells in cancer 6
-
- Ferroptosis and cancer prognosis 4
-
- Chromatography in Natural Products 4
- Analytical chemistry methods development 4
-
- Nanoplatforms for cancer theranostics 4
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Runtian Wang
39 papers receiving 777 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 151
- Oncology 233
- Immunology 127
- Molecular Biology 376
- Pulmonary and Respiratory Medicine 129
Countries citing papers authored by Runtian Wang
This map shows the geographic impact of Runtian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runtian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runtian Wang more than expected).
Fields of papers citing papers by Runtian Wang
This network shows the impact of papers produced by Runtian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runtian Wang. The network helps show where Runtian Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Runtian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 90 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 33 | |
| 9 | 2021 | 24 | |
| 10 | 2021 | 27 | |
| 11 | 2021 | 6 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 18 | |
| 15 | 2019 | 13 | |
| 16 | Reversing effects and target molecules of different traditional Chinese medicines on T cell immunosuppressions caused by colorectal cancer cells | 2011 | 1 |
| 17 | Comparision of down-regulating effects of different anti-tumor traditional Chinese medicines on immunosuppressions caused by colorectal tumor cells. | 2010 | 1 |
| 18 | Study on the down-regulatory effects of Ligustrazine Hydrochloride on tumor-induced immunosuppression by Colon26 tumor cells in vitro. | 2009 | 1 |
| 19 | Analysis of the expression of cytokines and adherent molecules in 20 cases with aplastic anemia | 2002 | 1 |
| 20 | Effects of shenmai injection on expression of TNF-alpha mRNA in peritoneal macrophages of scald mice. | 2002 | 4 |
About Runtian Wang
Runtian Wang is a scholar working on Analytical Chemistry, Pharmacology and Cancer Research, having authored 43 papers that have together received 790 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Immune cells in cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Ferroptosis and cancer prognosis (4 papers), Chromatography in Natural Products (4 papers), Nanoplatforms for cancer theranostics (4 papers), Analytical chemistry methods development (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (151 citations), Oncology (233 citations) and Immunology (127 citations). Runtian Wang has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Xiaoxiang Guan, Kun Xu, Fangyan Gao, Kaijuan Wang, Cenzhu Wang, Qin Hu, Xintong Li, Qun Xue, Chengjun Zhu and Jinyi Huang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.